{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:56:07Z","timestamp":1793368567066,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijbiomac.2021.06.024","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T08:59:35Z","timestamp":1622883575000},"page":"2162-2173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates"],"prefix":"10.1016","volume":"183","author":[{"given":"Ze-Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Huan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0010","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0015","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1016\/j.vaccine.2018.10.009","article-title":"Establishment of a novel safety assessment method for vaccine adjuvant development","volume":"36","author":"Sasaki","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/156652407780059140","article-title":"Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines","volume":"7","author":"Jennings","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","article-title":"Neutralizing antiviral B cell responses","volume":"15","author":"Bachmann","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0030","series-title":"Nanovaccines: An Innovative Technology to Fight Human and Animal Diseases","first-page":"267","article-title":"Virus-like particles-based mucosal nanovaccines","author":"Rosales-Mendoza","year":"2019"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nbt874","article-title":"Fabrication of novel biomaterials through molecular self-assembly","volume":"21","author":"Zhang","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"Lopez-Sagaseta","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0050","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1073\/pnas.78.9.5275","article-title":"Molecular engineering: An approach to the development of general capabilities for molecular manipulation","volume":"78","author":"Drexler","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.copbio.2017.03.018","article-title":"Bioengineering towards self-assembly of particulate vaccines","volume":"48","author":"Rehm","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","article-title":"Harnessing self-assembled peptide nanoparticles in epitope vaccine design","volume":"35","author":"Negahdaripour","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0070","first-page":"27","article-title":"Receptor dissociation and B-cell activation","volume":"393","author":"Yang","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","article-title":"Biodegradable particles as vaccine delivery systems: size matters","volume":"15","author":"Joshi","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2007.12.002","article-title":"Endocytosis mechanisms and the cell biology of antigen presentation","volume":"20","author":"Burgdorf","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/181646","article-title":"An overview on the field of micro- and nanotechnologies for synthetic peptide-based vaccines","volume":"2011","author":"Salvador","year":"2011","journal-title":"J. Drug. Deliv."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/vim.2017.0026","article-title":"Modes of action for mucosal vaccine adjuvants","volume":"30","author":"Aoshi","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bip.22759","article-title":"Different applications of virus-like particles in biology and medicine: vaccination and delivery systems","volume":"105","author":"Shirbaghaee","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-1135(00)00306-0","article-title":"Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination","volume":"78","author":"de Smit","year":"2001","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2011.08.025","article-title":"Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins","volume":"420","author":"Gavrilov","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03798-3","article-title":"Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines","volume":"7","author":"Leneghan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0120","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-019-0446-6","article-title":"A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection","volume":"17","author":"Li","year":"2019","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001556","article-title":"Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of plasmodium falciparum circumsporozoite protein","volume":"3","author":"Gregson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nature18010","article-title":"Design of a hyperstable 60-subunit protein dodecahedron. [corrected]","volume":"535","author":"Hsia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/vim.2014.0041","article-title":"Immune response to Fc tagged GP5 glycoproteins of porcine reproductive and respiratory syndrome virus","volume":"27","author":"Wu","year":"2014","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-020-1713-2","article-title":"Identification of E2 with improved secretion and immunogenicity against CSFV in piglets","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-017-0434-5","article-title":"Surface displaying of swine IgG1 Fc enhances baculovirus-vectored vaccine efficacy by facilitating viral complement escape and mammalian cell transduction","volume":"48","author":"Liu","year":"2017","journal-title":"Vet. Res."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imbio.2012.01.021","article-title":"The mouse dendritic cell marker CD11c is down-regulated upon cell activation through toll-like receptor triggering","volume":"218","author":"Singh-Jasuja","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0160","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.carbpol.2013.10.078","article-title":"Preparation and in vitro immunomodulatory effect of curdlan sulfate","volume":"102","author":"Li","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0165","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/j.vaccine.2012.03.049","article-title":"Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2","volume":"30","author":"Tian","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0170","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/j.vaccine.2018.10.030","article-title":"Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-\u03b3 as immunoadjuvant in weaning piglets","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0180","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jeb.00642","article-title":"Prime-boost strategies for malaria vaccine development","volume":"206","author":"Dunachie","year":"2003","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0185","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2567.2005.02268.x","article-title":"Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles","volume":"117","author":"Shen","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-017-0295-0","article-title":"The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria","volume":"15","author":"Karch","year":"2017","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-019-0712-5","article-title":"Nanoparticle-based vaccine development and evaluation against viral infections in pigs","volume":"50","author":"Dhakal","year":"2019","journal-title":"Vet. Res."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: from whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0220","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fcimb.2018.00232","article-title":"Structure-based design of porcine circovirus type 2 chimeric VLPs (cVLPs) displays foreign peptides on the capsid surface","volume":"8","author":"Wang","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030592","article-title":"Nanoreactor design based on self-assembling protein nanocages","volume":"20","author":"Ren","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0235","article-title":"A universal influenza nanovaccine for \u201cmixing vessel\u201d hosts confers potential ability to block cross-species transmission","volume":"8","author":"Ding","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0240","doi-asserted-by":"crossref","first-page":"102223","DOI":"10.1016\/j.nano.2020.102223","article-title":"A novel rapid modularized hepatitis B core virus-like particle-based platform for personalized cancer vaccine preparation via fixed-point coupling","volume":"28","author":"Ji","year":"2020","journal-title":"Nanomedicine-Uk"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0245","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-based vaccine antigen design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0255","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0260","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.7150\/thno.44564","article-title":"Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0265","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fmicb.2020.01961","article-title":"Self-assembly M2e-based peptide nanovaccine confers broad protection against influenza viruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2012.04.026","article-title":"Virus-like particles: the new frontier of vaccines for animal viral infections","volume":"148","author":"Crisci","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0275","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like particles: flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0280","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.2147\/IJN.S140789","article-title":"Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2","volume":"12","author":"Ding","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/vaccines8020197","article-title":"Construction and immunogenicity of a novel multivalent vaccine prototype based on conserved influenza virus antigens","volume":"8","author":"Kirsteina","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0295","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1016\/j.biomaterials.2013.07.063","article-title":"The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0300","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17452759.2011.631324","article-title":"A route toward the development of 3D magnetic scaffolds with tailored mechanical and morphological properties for hard tissue regeneration: preliminary study","volume":"6","author":"De Santis","year":"2011","journal-title":"Virtual Phys. Prototyp."},{"key":"10.1016\/j.ijbiomac.2021.06.024_bb0310","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1038\/s41598-020-74949-2","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.136973","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021012241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021012241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:12:31Z","timestamp":1730862751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021012241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":62,"alternative-id":["S0141813021012241"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.024","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijbiomac.2024.136973","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}